Comparative Effects of Sensory Augmentation and Neuromodulation on Enhancing Motor Recovery Among Stroke Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-56
SponsorLahore University of Biological and Applied Sciences

About this trial

This study aims to evaluate the effectiveness of two rehabilitation techniques-Sensory Augmentation (using mirror therapy) and Neuromodulation (using transcranial direct current stimulation, tDCS)-in improving motor recovery among stroke survivors. Stroke often results in long-term impairments, particularly in upper limb motor function, which is critical for daily activities. Although current rehabilitation strategies help, more effective solutions are needed to enhance recovery. Participants, aged 45-65 with chronic stroke and upper extremity impairments, will be randomized into three groups: Group 1 will receive a combination of sensory augmentation (mirror therapy) and neuromodulation (tDCS) with routine physical therapy; Group 2 will receive sensory augmentation (mirror therapy) with routine physical therapy; and Group 3 will receive neuromodulation (tDCS) with routine physical therapy. The interventions will take place four times a week for 8 weeks, and participants will undergo motor function assessments, including the Fugl-Meyer Assessment and Jebsen-Taylor Test, before and after the intervention. The study will compare the effects of each intervention on motor recovery, specifically focusing on upper limb function and motor control. The findings could lead to improved rehabilitation protocols, offering stroke survivors better therapeutic options and enhancing their quality of life.

Eligibility criteria

Qualifiers

Age: 45-65

Gender: both male and female

Ischemic stroke

Diagnosed cases of middle cerebral artery stroke by neurologist

Disqualifiers

Vestibular Dysfunction

Serious cognitive impairment,

Severe vision or visuospatial neglect

Spasticity (Modified Ashworth scale >3)

Trial design

Treatments tested in this trial

  • Sensory Augmentation
  • Neuromodulation
  • Combination of Sensory Augmentation and Neuromodulation

Treatment groups

36 Participants
are divided into 3 treatment groups